BioSpace News Archive

Dr. Simons will lead development of custom sequencing technology for antibody screening and immune function analysis

Agriculture Division to be Corteva Agriscience™, reflecting its purpose of enriching the lives of those who produce and consume. Materials Science Division will be called Dow, and will retain the Dow diamond as its brand, building on the Company’s globally recognized 121-year history of innovation and value creation. Specialty Products Division to be the new DuPont, carrying forward a 215-year legacy of science-based innovation to transform industries and everyday life.

The current influenza season has been especially difficult, causing widespread illness that has affected all fifty states and resulted in a record number of hospitalizations. While healthcare professionals continue to combat...

Clovis Oncology reported financial results for the quarter and year ended December 31, 2017, and provided an update on the Company’s clinical development programs and regulatory and commercial outlook for 2018.

The II-ON brings industry and academia together with the goal of advancing Immuno-Oncology research

Under the terms of the agreement, Centene will acquire 100 percent of the stock of MHM, including its 49 percent ownership of Centurion, the correctional healthcare services joint venture between Centene and MHM.

U.S. Patent Trial and Appeal Board denies St. Regis Mohawk Tribe’s motion to terminate Restasis patent challenge.

Expanded Partnership Leverages Selexis’ Expertise in Recombinant Therapeutic Development Solutions

New Liquid Biopsy Test Helps Physicians Select Most Effective Treatment, Prolonging Lives of Men with Metastatic Castration-resistant Prostate Cancer